We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-3.51%
1 Year Est. Return
+28.4%
3 Year Est. Return
+87.65%
5 Year Est. Return
10 Year Est. Return
AUM
$975M
AUM Growth
-$56.8M
Cap. Flow
-$5.68M
Cap. Flow %
-0.58%
Top 10 Hldgs %
35.66%
Holding
694
New
35
Increased
143
Reduced
163
Closed
20

Top Buys

Rank Stock Value
1
CHWY icon
Chewy
CHWY
+$2.15M
2
BEPC icon
Brookfield Renewable
BEPC
+$1.38M
3
RMD icon
ResMed
RMD
+$1.24M
4
CSW
CSW Industrials
CSW
+$832K
5
BN icon
Brookfield
BN
+$650K

Top Sells

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$2.51M
2
PANW icon
Palo Alto Networks
PANW
+$1.25M
3
AAPL icon
Apple
AAPL
+$1.1M
4
NVDA icon
NVIDIA
NVDA
+$1.03M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$966K

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Healthcare 16%
3 Industrials 12.66%
4 Consumer Discretionary 12.07%
5 Communication Services 11.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTWO icon
651
Q2 Holdings
QTWO
$3.78B
$1.65K ﹤0.01%
51
PCVX icon
652
Vaxcyte
PCVX
$7.65B
$1.63K ﹤0.01%
32
RPAY icon
653
Repay Holdings
RPAY
$335M
$1.56K ﹤0.01%
205
RJF icon
654
Raymond James Financial
RJF
$33.5B
$1.51K ﹤0.01%
+15
New +$1.59K
FITB
655
Fifth Third Bancorp
FITB
$51.3B
$1.46K ﹤0.01%
58
+2
+4% +$54
CYTK icon
656
Cytokinetics
CYTK
$10.6B
$1.44K ﹤0.01%
49
MRUS
657
DELISTED
Merus
MRUS
$1.42K ﹤0.01%
60
FIGS icon
658
FIGS
FIGS
$1.76B
$1.15K ﹤0.01%
195
CGEM icon
659
Cullinan Oncology
CGEM
$1.06B
$1.15K ﹤0.01%
127
PLRX icon
660
Pliant Therapeutics
PLRX
$65M
$1.13K ﹤0.01%
65
DYN icon
661
Dyne Therapeutics
DYN
$4.68B
$1.12K ﹤0.01%
125
KURA icon
662
Kura Oncology
KURA
$793M
$1.05K ﹤0.01%
115
LLYVA icon
663
Liberty Live Group Series A
LLYVA
$9.21B
$1.02K ﹤0.01%
+32
New +$1.05K
CYRX icon
664
CryoPort
CYRX
$753M
$960 ﹤0.01%
70
AGGY icon
665
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$921M
$955 ﹤0.01%
23
TWST icon
666
Twist Bioscience
TWST
$5.32B
$649 ﹤0.01%
32
STRO icon
667
Sutro Biopharma
STRO
$386M
$622 ﹤0.01%
18
HRTX icon
668
Heron Therapeutics
HRTX
$93.4M
$379 ﹤0.01%
367
SPCE icon
669
Virgin Galactic
SPCE
$315M
$180 ﹤0.01%
5
EMBC icon
670
Embecta
EMBC
$218M
$76 ﹤0.01%
5
-5
-50% -$94
BATRK icon
671
Atlanta Braves Holdings Series B
BATRK
$3.28B
$36 ﹤0.01%
+1
New +$38
CFRX
672
DELISTED
ContraFect Corporation
CFRX
$3 ﹤0.01%
5
OPTT icon
673
Ocean Power Technologies
OPTT
$41.5M
$1 ﹤0.01%
1
ALEC icon
674
Alector
ALEC
$169M
-156
Closed -$938
CAG icon
675
Conagra Brands
CAG
$7.42B
-212
Closed -$7.15K

Similar funds

Washington Trust Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Washington Trust Advisors held 694 positions worth $975M, down 5.5% from $1.03B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Washington Trust Advisors's Q3 2023 filing shows 35 new, 143 increased, 163 reduced and 20 closed positions. Its largest new stake was Penumbra: 2,071 shares worth $501K. The largest sale was Quanta Services, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Washington Trust Advisors's largest Q3 2023 buy was Penumbra: 2,071 shares worth $501K.
  • Washington Trust Advisors added most to Chewy in Q3 2023, an estimated $2.15M increase.
  • Washington Trust Advisors's biggest Q3 2023 reduction was Quanta Services, cutting an estimated $2.51M.
  • Washington Trust Advisors fully exited VanEck Long Muni ETF in Q3 2023, selling an estimated $153K.
  • Washington Trust Advisors's ten largest holdings make up 36% of its $975M portfolio in Q3 2023.
  • Washington Trust Advisors opened 35 new positions and closed 20 in Q3 2023.
  • Washington Trust Advisors's portfolio value fell 5.5% quarter-over-quarter to $975M.

Based on Washington Trust Advisors's 13F filing for Q3 2023, filed 18 Oct 2023.